Omega Healthcare Investors heads into its July 29 earnings report with options positioning at its most bullish in a year — a sharp contrast to the cautious stance investors held just weeks ago.
The clearest signal is in call-side demand. The put/call ratio has dropped to 0.35, the lowest reading of the past 52 weeks and nearly 2.7 standard deviations below its 20-day average of 0.56. That kind of skew reflects heavy call accumulation relative to puts — options traders are leaning decidedly toward upside into the print. The shift is recent and abrupt: the PCR ran close to 0.60 for most of June and early July before breaking lower in the past two sessions.
The underlying price action supports that tilt. OHI has gained 11.4% over the past month, closing at $51.72, and added another 3% on the week. Peers moved in the same direction — SBRA jumped 11.2% on the week while VTR added 4.6% — but OHI's one-month move is the more notable re-rating. The borrow market offers no resistance to that momentum: availability is extremely loose at over 2,400%, with borrowing costs down 24% on the week to just 0.29%. Short interest at 4.7% of the float has edged lower over the past week, and there is no meaningful short-side pressure to speak of.
The analyst picture is more divided. Barclays initiated coverage on July 7 with an Underweight rating and a $51 target — essentially flagging the stock as fairly valued right at current levels. Raymond James reinstated an Outperform at $50 in June, while UBS maintained its Buy and raised its target to $54. The stock has now run through most of those targets. Bears point to reimbursement risk, labor cost pressures on operators, and an EPS forward growth picture that ranks in just the 32nd percentile of the universe. Bulls counter with demographic tailwinds from an ageing population, a triple-net lease structure that insulates Omega from direct operating costs, and a portfolio spanning 929 facilities across North America and the UK. One note of caution: OHI's CEO sold $5.4 million of stock on June 1 — the most significant insider transaction in recent months — which carries a different message than the options market's bullish lean.
The July 29 print will test whether OHI's 11% re-rating over the past month reflects a genuine acceleration in operator coverage ratios and same-store growth, or whether the stock has simply run ahead of what the numbers can deliver.
See the live data behind this article on ORTEX.
Open OHI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
